Almirall S.A. | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
89,729.00
481,977.00
172,636.00
92,637.00
321,063.00
74,974
Depreciation, Depletion & Amortization
69,445.00
84,709.00
74,250.00
100,296.00
103,660.00
90,180
Other Funds
3,699.00
2,569.00
-
-
323,550.00
29,126
Funds from Operations
52,048.00
595,993.00
94,280.00
82,409.00
1,646.00
136,028
Changes in Working Capital
15,066.00
36,202.00
61,239.00
8,687.00
12,812.00
5,059
Net Operating Cash Flow
67,114.00
632,195.00
155,519.00
91,096.00
11,166.00
141,087
Capital Expenditures
63,653.00
69,447.00
26,771.00
82,086.00
69,055.00
Sale of Fixed Assets & Businesses
-
20,392.00
63,928.00
50,633.00
272.00
Purchase/Sale of Investments
14,497.00
16,190.00
29,647.00
6,449.00
-
Net Investing Cash Flow
306,974.00
1,990.00
5,550.00
458,454.00
68,769.00
Cash Dividends Paid - Total
826.00
-
35,000.00
33,000.00
33,000.00
Issuance/Reduction of Debt, Net
281,422.00
37,587.00
1,407.00
927.00
250,000.00
Net Financing Cash Flow
276,780.00
35,018.00
36,407.00
33,927.00
106,550.00
Net Change in Cash
36,920.00
665,223.00
113,562.00
401,285.00
186,485.00
Free Cash Flow
52,519.00
592,047.00
143,009.00
66,724.00
29,952.00
Net Assets from Acquisitions
231,730.00
18,660.00
13,541.00
433,450.00
-
Other Sources
2,906.00
49,535.00
2,825.00
-
62.00
Change in Capital Stock
117.00
-
-
-
-
Other Uses
-
-
2,344.00
-
48.00

About Almirall

View Profile
Address
Ronda General Mitre, 151
Barcelona Catalonia 08022
Spain
Employees -
Website http://www.almirall.com
Updated 07/08/2019
Almirall SA engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The company operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological and gastrointestinal diseases.